Article
Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses
28 Sept 2021
Abstract excerpt
Understanding mechanisms of protective antibody recognition can inform vaccine and therapeutic strategies against SARS-CoV-2. We report a monoclonal antibody, 910-30, targeting the SARS-CoV-2 receptor-binding site for ACE2 as a member of a public antibody response encoded by IGHV3-53/IGHV3-66 genes. Sequence and structural analyses of 910-30 and related antibodies explore how class recognition features correlate...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
